Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Venous Thrombosis

  Free Subscription


20.02.2017

1 Cardiovasc Intervent Radiol
2 Circ Cardiovasc Interv
1 Thromb Haemost
1 Thromb Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Cardiovasc Intervent Radiol

  1. UEDA T, Murata S, Miki I, Yasui D, et al
    Endovascular Treatment Strategy Using Catheter-Directed Thrombolysis, Percutaneous Aspiration Thromboembolectomy, and Angioplasty for Acute Upper Limb Ischemia.
    Cardiovasc Intervent Radiol. 2017 Feb 9. doi: 10.1007/s00270-017-1599.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Interv

  2. KAWAKAMI T, Ogawa A, Miyaji K, Mizoguchi H, et al
    Response by Kawakami et al to Letter Regarding Article, "Novel Angiographic Classification of Each Vascular Lesion in Chronic Thromboembolic Pulmonary Hypertension Based on Selective Angiogram and Results of Balloon Pulmonary Angioplasty".
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format    

  3. ROIK M, Wretowski D, Pruszczyk P
    Letter by Roik et al Regarding Article, "Novel Angiographic Classification of Each Vascular Lesion in Chronic Thromboembolic Pulmonary Hypertension Based on Selective Angiogram and Results of Balloon Pulmonary Angioplasty".
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format    


    Thromb Haemost

  4. HEIT JA, Armasu SM, McCauley BM, Kullo IJ, et al
    Identification of unique venous thromboembolism-susceptibility variants in African-Americans.
    Thromb Haemost. 2017 Feb 16. doi: 10.1160/TH16-08-0652.
    PubMed     Text format     Abstract available


    Thromb Res

  5. THEBERGE I, Bowdridge J, Forgie MA, Carrier M, et al
    Rivaroxaban shows promise as effective therapy for cancer patients with venous thromboembolic disease.
    Thromb Res. 2017;152:4-6.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: